The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway

Oncogene

Volumn 34, Issue 10, 2015, Pages 1280-1291

  Sato, T ^a   Takahashi, H ^a   Hatakeyama, S ^a   Iguchi, A ^a   Ariga, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GNB2L1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN BINDING; PROTEIN C JUN; PROTEIN KINASE C; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TRIM45 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL; CELL LINE; CELL PROLIFERATION; CHEMISTRY; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84896691119     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.68     Document Type: Article

References (47)

1. Avruch J. MAP kinase pathways: the first twenty years. Biochim Biophys Acta 2007; 1773: 1150-1160.
2. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007; 26: 3100-3112.
3. Calvo F, Agudo-Ibanez L, Crespo P. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies. Bioessays 2010; 32: 412-421.
4. Kondoh K, Nishida E. Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 2007; 1773: 1227-1237.
5. Imajo M, Tsuchiya Y, Nishida E. Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life 2006; 58: 312-317.
6. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B et al. MAP kinases. Chem Rev 2001; 101: 2449-2476.
7. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869.
8. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320-344.
9. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011; 75: 50-83.
10. Maurer G, Tarkowski B, Baccarini M. Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 2011; 30: 3477-3488.
11. Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol 2008; 10: 1324-1332.
12. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M et al. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 2007; 11: 447-460.
13. Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci USA 1994; 91: 839-843.
14. Ron D, Luo J, Mochly-Rosen D. C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo. J Biol Chem 1995; 270: 24180-24187.
15. Ron D, Mochly-Rosen D. An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci USA 1995; 92: 492-496.
16. Dorn GW 2nd, Mochly-Rosen D. Intracellular transport mechanisms of signal transducers. Annu Rev Physiol 2002; 64: 407-429.
17. McCahill A, Warwicker J, Bolger GB, Houslay MD, Yarwood SJ. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol Pharmacol 2002; 62: 1261-1273.
18. Al-Reefy S, Osman H, Jiang W, Mokbel K. Evidence for a pro-apoptotic function of RACK1 in human breast cancer. Oncogene 2010; 29: 5651, author reply 2.
19. Bourd-Boittin K, Le Pabic H, Bonnier D, L'Helgoualc'h A, Theret N. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis. J Biol Chem 2008; 283: 26000-26009.
20. Zhang W, Cheng GZ, Gong J, Hermanto U, Zong CS, Chan J et al. RACK1 and CIS mediate the degradation of BimEL in cancer cells. J Biol Chem 2008; 283: 16416-16426.
21. Shi S, Deng YZ, Zhao JS, Ji XD, Shi J, Feng YX et al. RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway. J Biol Chem 2012; 287: 7845-7858.
22. Bauman AL, Scott JD. Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo. Nat Cell Biol 2002; 4: E203-E206.
23. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z. RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell 2005; 19: 309-320.
24. Lopez-Bergami P, Ronai Z. Requirements for PKC-augmented JNK activation by MKK4/7. Int J Biochem Cell Biol 2008; 40: 1055-1064.
25. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005; 3: 799-808.
26. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140-2151.
27. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 2005; 27: 1147-1157.
28. Noguchi K, Okumura F, Takahashi N, Kataoka A, Kamiyama T, Todo S et al. TRIM40 promotes neddylation of IKKgamma and is downregulated in gastrointestinal cancers. Carcinogenesis 2011; 32: 995-1004.
29. Sato T, Okumura F, Kano S, Kondo T, Ariga T, Hatakeyama S. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription. J Cell Sci 2011; 124: 3492-3502.
30. Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N et al. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res 2008; 68: 3486-3494.
31. Kano S, Miyajima N, Fukuda S, Hatakeyama S. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res 2008; 68: 5572-5580.
32. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 1997; 17: 285-291.
33. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011; 11: 792-804.
34. Wang Y, Li Y, Qi X, Yuan W, Ai J, Zhu C et al. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. Biochem Biophys Res Commun 2004; 323: 9-16.
35. Adams DR, Ron D, Kiely PA. RACK1, a multifaceted scaffolding protein: structure and function. Cell Commun Signal 2011; 9: 22.
36. Shibata M, Sato T, Nukiwa R, Ariga T, Hatakeyama S. TRIM45 negatively regulates NF-kappaB-mediated transcription and suppresses cell proliferation. Biochem Biophys Res Commun 2012; 423: 104-109.
37. Chou YC, Chou CC, Chen YK, Tsai S, Hsieh FM, Liu HJ et al. Structure and genomic organization of porcine RACK1 gene. Biochim Biophys Acta 1999; 1489: 315-322.
38. He DY, Neasta J, Ron D. Epigenetic regulation of BDNF expression via the scaffolding protein RACK1. J Biol Chem 2010; 285: 19043-19050.
39. Soh JW, Weinstein IB. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 2003; 278: 34709-34716.
40. Rotenberg SA, Sun XG. Photoinduced inactivation of protein kinase C by dequalinium identifies the RACK-1-binding domain as a recognition site. J Biol Chem 1998; 273: 2390-2395.
41. Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 2010; 10: 65-76.
42. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 2002; 22: 2871-2881.
43. Wei W, Jin J, Schlisio S, Harper JW, Kaelin Jr WG. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 2005; 8: 25-33.
44. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005; 113: 951-960.
45. Takahashi H, Parmely TJ, Sato S, Tomomori-Sato C, Banks CA, Kong SE et al. Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 2011; 146: 92-104.
46. Sato T, Okumura F, Ariga T, Hatakeyama S. TRIM6 interacts with Myc and maintains the pluripotency of mouse embryonic stem cells. J Cell Sci 2012; 125: 1544-1555.
47. Takahashi H, Hatakeyama S, Saitoh H, Nakayama KI. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. J Biol Chem 2005; 280: 5611-5621.